- $378.28m
- $335.78m
- $235.11m
- 66
- 46
- 68
- 62
C2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 253 | 216 | 214 | 219 | 235 |
Cost of Revenue | |||||
Gross Profit | 168 | 148 | 143 | 149 | 158 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 239 | 221 | 241 | 246 | 264 |
Operating Profit | 14.2 | -5.26 | -26.1 | -27.1 | -28.9 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 14.4 | -3.42 | -26.1 | -11.7 | -27.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.86 | -5.46 | -30.6 | -14.4 | -29.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.86 | -5.46 | -30.6 | -14.4 | -29.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.86 | -5.46 | -30.6 | -14.4 | -29.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.196 | -0.136 | -0.772 | -0.144 | -0.461 |
Dividends per Share |